Na stronę główną

Jak to działa

Zmieniliśmy proces wyszukiwania kliniki, czyniąc go prostym, szybkim i spersonalizowanym.
Proszę odpowiedzieć na kilka pytańProszę wypełnić krótki formularz, aby opowiedzieć nam o swoim stanie zdrowia i potrzebach medycznych.
Proszę otrzymać spersonalizowane oferty3 kliniki, wybrane na podstawie Państwa odpowiedzi, przedstawią spersonalizowane programy i ceny.
Proszę wybrać najlepszą opcjęProszę porównać oferty i wybrać klinikę, która najbardziej Państwu odpowiada.
Mogą Państwo również przejrzeć wszystkie 6 klinik poniżej.
820К+ pacjentów otrzymało pomoc od 2014 roku
50 kraje
1,500 kliniki
6K+ opinie
3K+ wykwalifikowani lekarze

Jaka jest cena procedur diagnostycznych i leczenia rhabdomyosarcomy w Izraelu? Proszę dowiedzieć się teraz

Rhabdomyosarcoma treatment cost in Israel typically involves diagnostics like a PET/CT scan from $1,300 to $1,800 and primary interventions such as the removal of rhabdomyosarcoma which ranges from $900 to $1,300. Total expenses depend on tumor stage, the necessity of combined chemotherapy, and the hospital's tier. Patients generally save 30-80% compared to the US. Top treatment centers are located in Tel Aviv, Ramat Gan, and Jerusalem.

Typical Rhabdomyosarcoma Treatment Costs in Israel

  • Consultation with an oncologist: $400 – $600
  • PET-CT: $1,300 – $1,800
  • CT (computer tomography): $200 – $500
  • Removal of rhabdomyosarcoma: $900 – $1,300

Bookimed Expert Insight: Pediatric cases benefit most from multidisciplinary teams at JCI-accredited centers like Sourasky Medical Center. They report a 90% average success rate in oncology. For complex bone or soft tissue involvement, clinics with Forbes-listed specialists like Hadassah Medical Center offer high-volume surgical expertise. Private options like Assuta Medical Center are best for patients seeking rapid access to specific surgeons and personalized room types.

IzraelTurcjaAustria
Usunięcie rhabdomyosarcomyod $855od $15,000od $30,000
Chemioterapia w raku piersiod $22,500od $1,200od $15,000
Złożone leczenie mięśniakomięsaka prążkowanokomórkowego-od $45,000-
Radioterapia raka odbytnicy-od $7,000od $12,000
Radioterapia przy mięsakach-od $3,250od $18,000
Dane zweryfikowane przez Bookimed na May 2026, na podstawie zapytań pacjentów i oficjalnych wycen z 52 klinik na całym świecie. Koszty mediany opierają się na rzeczywistych fakturach (2025–2026) i są aktualizowane co miesiąc. Rzeczywiste ceny mogą się różnić.

Dowiedzieć się o najlepszych klinikach w leczeniu rhabdomyosarcomy w Izraelu: 6 sprawdzonych klinik i ceny

Ranking klinik Bookimed opiera się na algorytmach data science. Jego podstawą są takie kryteria: liczba zapytań od pacjentów, opinie (pozytywne i negatywne), aktualność cen i opcji leczenia, szybkość odpowiedzi kliniki oraz posiadanie certyfikatów.
Sourasky Medical Center (Ichilov)
Centrum Medyczne Sheba
Assuta Medical Center
Rambam Medical Center
Centrum Medyczne Hadassah

Uzyskać ocenę medyczną w leczeniu rhabdomyosarcomy w Izraelu: znaleźć swojego specjalistę wśród 9 doświadczonych lekarzy

Wszyscy lekarze
zweryfikowany

Ofer Merimsky

41 lat doświadczenia

Prof. Merimsky od ponad 25 lat specjalizuje się w onkologii tkanek miękkich i kości. Kieruje oddziałem mięsaków w Centrum Medycznym Sourasky.

  • Odbył staż specjalistyczny w zakresie mięsaków w Institut Gustave Roussy w Paryżu
  • Jest członkiem panelu ekspertów ESMO ds. mięsaków tkanek miękkich i kości
  • Kierował katedrą onkologii na Uniwersytecie w Tel Awiwie
  • Opublikował liczne prace badawcze na temat nowotworów kości i tkanek miękkich
zweryfikowany

Ronit El Hasid

38 lat doświadczenia

Dr El Hasid wykonała ponad 300 przeszczepów szpiku kostnego i krwi pępowinowej u dzieci jako ordynator onkologii dziecięcej w szpitalu Dana Dwek.

  • Specjalizuje się w metodach leczenia nowotworów dziecięcych opartych na transplantacji
  • Opublikowała ponad 50 prac medycznych i przedstawiła 40 raportów konferencyjnych
  • Jest członkiem Amerykańskiego Towarzystwa Hematologicznego oraz Izraelskiego Towarzystwa Onkologii Dziecięcej
  • Odbyła międzynarodowe szkolenie w szpitalu City of Hope w Los Angeles
zweryfikowany

Yuri Goldes

28 lat doświadczenia

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

zweryfikowany

Dror Levin

41 lat doświadczenia

Dr Dror Levin jest cenionym onkologiem dziecięcym w Izraelu, specjalizującym się w sarkoimach u dzieci w Centrum Medycznym Sourasky.

  • Studiował onkologię mięsaków dziecięcych w światowej sławy Instytucie Ortopedycznym Rizzoli w Bolonii.
  • Jako dyrektor oddziału hematoonkologii dziecięcej w Sourasky, koordynuje leczenie mięsaków u dzieci.
  • Jest członkiem Izraelskiego Towarzystwa Hematologii i Onkologii Dziecięcej (ISPHO).
  • Jego wiedza specjalistyczna obejmuje hematologię dziecięcą, onkologię oraz specjalistyczną opiekę nad pacjentami z nowotworami kości.

Udostępnić tę treść

Wideo historie pacjentów Bookimed

Dayana
I combined my vacation in Antalya with a check-up.
Procedura: Badanie kontrolne dla kobiet
Igor
It was great! Transfers, accommodation, treatment—all included.
Procedura: Implantacja zębów
Marina
Bookimed did everything for me. I didn't have to worry about anything.
Procedura: Badanie kontrolne dla kobiet
Zaktualizowano: 05/27/2022
Autor
Anna Leonova
Anna Leonova
Kierownik działu marketingu treści
Certyfikowany autor tekstów medycznych z ponad 10-letnim doświadczeniem, odpowiada za wiarygodność treści Bookimed. Posiada tytuł magistra filologii, przeprowadzała wywiady z ekspertami światowymi.
Fahad Mawlood
Redaktor medyczny, Data Scientist
Lekarz ogólny, laureat 4 konkursów prac naukowych młodych naukowców. Pracował na Bliskim Wschodzie. Były kierownik zespołu anglojęzycznych i arabskojęzycznych lekarzy-koordynatorów. Obecnie zajmuje się analizą danych i jest redaktorem medycznym strony.
Fahad Mawlood Linkedin
Na tej stronie mogą być prezentowane informacje dotyczące różnych chorób, metod leczenia oraz usług medycznych dostępnych w różnych krajach. Proszę zauważyć, że treści mają charakter wyłącznie informacyjny i nie powinny być traktowane jako porada medyczna ani wytyczne. Proszę skonsultować się z lekarzem lub wykwalifikowanym pracownikiem medycznym przed rozpoczęciem lub zmianą leczenia.

Wszystko, co trzeba wiedzieć o Rhabdomyosarcoma w Izrael

Zastrzeżenie medyczne: Ten artykuł ma wyłącznie charakter informacyjny i nie stanowi porady medycznej. Przed podjęciem jakichkolwiek decyzji medycznych należy zawsze skonsultować się z wykwalifikowanym specjalistą ochrony zdrowia. Wyniki mogą się różnić. Przeczytaj pełne zastrzeżenie

Rhabdomyosarcoma treatment in Israel

Rhabdomyosarcoma develops from a transversely striated (skeletal) muscle and is a colony of modified muscle cells (myocytes). In a result of a number of successive divisions, tumor elements are simplified and become similar to embryonic cells (precursors of muscles) that are rabdomioblasts. The longer the tumor does not being treat, the worse the prognosis for life is as there is the higher risk of metastasing and organ damage around tumors.

In two-thirds of cases, rhabdomyosarcoma affects the children up to 10 years, mainly boys (girls’ rate is in 2 times lower). Overwhelming majority of the illness cases (90%) is up to the age of 25 years.

Types of rhabdomyosarcoma:

  • embryonic rhabdomyosarcoma is typical for children and it affects the head and neck;
  • alveolar rhabdomyosarcoma develops mainly in adolescents. It affects the large skeletal muscles (quadriceps, triceps, back muscles);
  • botryoid rhabdomyosarcoma affects the muscle wall of the internal organs (vagina, urine bladder).

Only in Israel

  • assistance is provided by experts of global renown;
  • there are specialized clinics for the treatment of various types of sarcomas; Diagnosticians and oncologists of Israel know all the peculiarities of this type of tumors;
  • they use the most up-to-date diagnostic equipment;
  • excellent survival rates and curability of patients;
  • all-day care, patient and family support programs.
70% is an average survival index.
90% of full recovery by early treatment.

Causes of rhabdomyosarcoma

Major risk factors contributing to the development of rhabdomyosarcoma:

  • the irradiation of a mother or a child, especially during pregnancy;
  • concomitant genetic abnormalities as Li-Fraumeni syndrome, albinism or neurofibromatosis. The process is more common for children with a giant melanocytic nevus;
  • constant contact with carcinogens (including food) and toxic substances.

Rhabdomyosarcoma usually develops in people with immunodeficiency. People infected with HIV, TB, children with any form of anemia are the most vulnerable. It is necessary to pay attention to the children previously treated with chemotherapy. In some cases, rhabdomyosarcoma develops after leukemia.

Symptoms of rhabdomyosarcoma

  • some tumors above the skin surface. They are painless and aren’t red; subdermal formation is dense and elastic;
  • after a while, there is some pain due to compression of the nerve endings by growing tumor;
  • bleeding and ulceration of sarcoma may occur;
  • regional lymph nodes are increased;
  • weakness is developing, the body weight is decreasing. There may be some intestinal dysmotility, nausea, loss of appetite.

Depending on the location of the main tumor, the disease manifests itself as follows:

  • unilateral exophthalmos (proptotic eyes) due to the location of rhabdomyosarcoma in the orbit;
  • blood-tinged discharges from the ear canal when the tumor is in the middle ear;
  • nose bleedings, nasal congestion when the tumor is in the nasal passages;
  • scrotal edema, blood in semen;
  • blood in the urine, the symptoms of cystitis (painful urination, pain шт lower abdomen) when the urine bladder wall is affected.

The symptoms at different stages of rhabdomyosarcoma:

Stage 1

Stage 2

nearly invisible tumor, no local reactions

visible (subdermal) tumor, some pain, redding

Stage 3

Stage 4

intense pain, enlarged lymph nodes

damage and dysfunction of organs, metastasing

Rhabdomyosarcoma diagnostics in Israel

  • the main method of rhabdomyosarcoma diagnostics is an MRI. The method allows to precisely localize the process, its relationship with the surrounding structures. Tumor is located deeply in the soft tissues and is not very different from the structure, so radiographic techniques are less effective;
  • MSCT for metastases screening and localization;
  • PET-CT for the determination of small foci of metastasis;
  • Ultrasound is used as a preliminary screening. As a rule, ultrasound is used with Doppler sonography;
  • scintigraphy is used for the diagnostics of bone metastases;
  • biopsy is used to determine the type of tumor. it does not only confirms the diagnosis, but also affects the intensity and duration of chemotherapy (it determines the invasiveness of the process and makes prognosis);
  • searching for tumor markers in the blood helps to confirm the ongoing process if there are difficulties in finding the primary focus.

Methods of rhabdomyosarcoma treatment in Israel

Israeli oncologists achieve excellent results even with common processes (3A-B stage):

  • surgical treatment. The entire tumor or most of it is removed (if the complete excision is not possible), as well as regional lymph nodes, and concerned tissues and organs;
  • chemotherapy of rhabdomyosarcoma. Israeli chemotherapists use innovative combinations of cytostatics and hormones, that increases the sensitivity of the tumor to treatment. On the 4th stage of the disease it is the main method. Targeted chemotherapy helps to achieve the maximum concentration of drug in the tumor body;
  • radiation therapy is applying in 2 months after chemotherapy. The impact is produced on the operated area of the body. With rhabdomyosarcoma of the central nervous system, radiation therapy is applied before chemotherapy;
  • transplantation of bone marrow stem cells. It is used due to destroying own stem cells by the necessary for the treatment doses of chemotherapy. When transplantation is possible, your doctor may significantly increase the dosage of chemotherapy drugs with no hesitating of subsequent complications such as aplastic anemia.

Review: a four-month-old infant with rhabdomyosarcoma

When my son was 4 months, doctors have found rhabdomyosarcoma. We had conducted 4 courses of chemotherapy and two surgeries, then aplastic anemia began. The doctor said that haemopoiesis was disrupted and we needed a bone marrow transplantation.

After the examination of relatives, it turned out that my brother can be a bone marrow donor. We have conducted stem cell transplantation.

Now the boy is 2 years old, he is often sick, but there are no tumor signs anymore. We take drugs (necessary for normal functioning of the transplanted bone marrow).”

Valentina, Turkmenistan

Rehabilitation after rhabdomyosarcoma removal, prevention of recurrence

Prediction for patients depends on the process stage. Even at the 4th stage, the five-year survival rate exceeds 30% (alveolar form of the disease). Careful attention to a patient after surgery and intensive chemotherapy allows to achieve full cure in 70% of all patients with rhabdomyosarcoma.

It is recommended to make regular visits to the oncologist (every 2 months during the first year after surgery) and periodic screening of tissues:

  • in the area of the removed tumor;
  • plain radiography of thoracic organs;
  • liver ultrasound.

Two recent studies allow quick identifying metastases in the process expansion.

Cost of rhabdomyosarcoma treatment in Israel

  • Prices for cancer center services in Israel are controlled by the state. This allows you to plan ahead the medical tour and optimize costs;
  • The cost of treatment is 20% lower than in Switzerland, the USA and Germany (the national average);
  • Bookimed company helps to avoid payment of intermediaries, that significantly reduce the overall cost of treatment;
  • High level of service due to which the patient and his/her family receive all the necessary support during treatment and the rehabilitation period.

FAQ dotyczące leczenia rhabdomyosarcomy w Izraelu

To pytania od prawdziwych pacjentów poszukujących pomocy medycznej przez Bookimed. Odpowiedzi udzielają doświadczeni lekarze-koordynatorzy oraz oficjalni przedstawiciele klinik.

What are the primary treatment options for rhabdomyosarcoma in Israel?

Primary treatment for rhabdomyosarcoma in Israel includes a multimodal approach combining surgical tumor removal, systemic chemotherapy, and precision radiation therapy. Israeli oncology centers utilize advanced molecular subtyping and genomic sequencing to personalize these treatments within JCI-accredited facilities.

  • Surgical intervention: Surgeons aim for complete resection while prioritizing limb preservation and functional outcomes.
  • Chemotherapy protocols: Mandatory systemic treatments often use the IVA or VAC drug combination regimens.
  • Precision radiation: Specialized centers use 3D navigation and dosimetry to target tumors accurately.
  • Supportive therapies: Treatment plans may include bone marrow transplantation and CAR-T or TIL immunotherapies.

Bookimed Expert Insight: Israeli oncology centers like Sourasky and Sheba specialize in complex bone and soft tissue cases. Dr. Ofer Merimsky and Dr. Boaz Liberman demonstrate that top specialists often lead national sarcoma units. This concentration of expertise allows for survival rates as high as 90% in certain oncology cases. Patients benefit most when specific pediatric hemato-oncologists, such as Dr. Iris Kventsel, manage the integration of surgery with advanced biological research.

Patient Consensus: Patients emphasize that starting fertility preservation before beginning intensive chemotherapy is a vital but often overlooked step. Families note the importance of achieving clean surgical margins to reduce recurrence risks during the year-long treatment journey.

Which hospitals in Israel specialize in rhabdomyosarcoma?

Sheba Medical Center and Sourasky Medical Center specialize in treating rhabdomyosarcoma. These JCI-accredited facilities offer multidisciplinary care for children and adults. Specialized units use precision medicine and genetic testing to guide treatment. Israel ranks 5th globally for medical services on Bookimed.

  • Sourasky Medical Center: Features the National Center for Sarcomas for pediatric and adult care.
  • Sheba Medical Center: Ranked 7th worldwide by Newsweek for advanced specialized treatments.
  • Lead expert: Prof. Ofer Merimsky heads the National Center for bone and soft tissue sarcomas.
  • Pediatric specialist: Dr. Iris Kventsel specializes in pediatric sarcomas including rhabdomyosarcoma and Ewing sarcoma.

Bookimed Expert Insight: While most patients look for general oncology, the most successful outcomes for rhabdomyosarcoma are linked to specialized sarcoma units. At Sourasky, Dr. Ofer Merimsky leads a dedicated center that integrates surgical oncology with 3D navigation. Sheba Medical Center uniquely offers CAR-T and TIL immunotherapies for complex cases. These specialized protocols are often missing in standard oncology departments at smaller clinics.

Patient Consensus: Patients emphasize choosing facilities that provide specialized pathology reviews to ensure diagnostic accuracy. Many note that choosing Sheba or Hadassah allowed them access to international collaboration for rare soft tissue cases.

What key questions should I ask the oncologist at the first consultation?

Patients should ask about the specific pediatric oncology protocols and multidisciplinary approaches used. Inquire about the stage of the rhabdomyosarcoma and its molecular subtype. Ask if precision medicine or immunotherapy options are available. Confirm the primary treatment goal and the expected success rates within the facility.

  • Diagnostic precision: Ask how PET-CT and genetic testing impact the personalized treatment plan.
  • Specialized experience: Inquire about the oncologist’s volume of pediatric rhabdomyosarcoma cases treated.
  • Technology access: Ask if robotic surgery or digital imaging will minimize healthy tissue damage.
  • Survival outcomes: Request institutional data on 5-year survival rates for this specific cancer stage.

Bookimed Expert Insight: Israeli oncology centers like Sheba Medical Center prioritize precision medicine and AI-driven diagnostics. Data shows these high-volume centers manage 1.9 million patients yearly. This volume allows doctors to gain deep expertise in rare pediatric tumors. Always ask if your child's case will be reviewed by a multidisciplinary tumor board. This ensures top-tier specialists from different fields collaborate on the best strategy.

Patient Consensus: Parents note that having a clear point of contact for daily updates is vital. They find it helpful to ask about emotional support services available during the long treatment process.

Why do families travel to Israel specifically for rhabdomyosarcoma care?

Families choose Israel for rhabdomyosarcoma care because of high success rates reaching 90% and specialized pediatric oncology departments. Israeli centers utilize advanced genomic sequencing to tailor molecular therapies. Experts like Dr. Ofer Merimsky lead national sarcoma units that integrate high-resolution PET/CT diagnostics.

  • Specialized expertise: Dedicated national bone and soft tissue sarcoma units coordinate complex pediatric treatments.
  • Advanced diagnostics: High-resolution PET/CT and molecular testing identify unique tumor profiles for precise targeting.
  • Limb-salvage techniques: Surgeons like Dr. Dror Levin prioritize functional reconstruction and limb preservation during surgery.
  • Elite credentials: Top specialists hold memberships in the American Society of Clinical Oncology (ASCO).

Bookimed Expert Insight: Israeli oncology centers like Sheba and Sourasky manage a combined annual volume of over 3.7 million patients. This massive throughput allows doctors to gain experience with extremely rare rhabdomyosarcoma subtypes. For example, Dr. Iris Kventsel focus on Li-Fraumeni syndrome ensures families receive highly specialized genetic monitoring alongside standard treatment.

Patient Consensus: Parents note that Israeli surgeons often pioneer limb-salvage techniques that are not available at local centers. Families also value the faster access to genome sequencing, which helps identify targeted drugs more quickly than elsewhere.

Which cutting-edge technologies are routinely used for rhabdomyosarcoma irradiation in Israel?

Israeli oncology centers use diverse irradiation technologies to treat rhabdomyosarcoma. These include Intensity-Modulated Radiation Therapy (IMRT), Volumetric Modulated Arc Therapy (VMAT), and TrueBeam STx linear accelerators. These tools allow for sub-millimeter tracking. Clinicians prioritize sparing healthy pediatric tissues and vital organs during targeted sessions.

  • Dynamic delivery: VMAT shapes high-energy beams to match multi-dimensional tumor structures.
  • Real-time tracking: TrueBeam STx corrects for patient movement during radiation sessions.
  • Image navigation: MRI-TRUS guided brachytherapy allows precise internal radioactive bead placement.
  • Motion management: 4D CT scanning tracks respiratory cycles to protect moving organs.

Bookimed Expert Insight: Israeli medical centers demonstrate a high standard of care through extensive JCI accreditations and immense patient volumes. Sheba Medical Center serves over 1,900,000 patients annually. This vast experience supports an average 90% success rate for oncology treatments at leading facilities like Sourasky Medical Center. Patients benefit from this specialized expertise in managing complex childhood sarcomas.

Patient Consensus: Patients emphasize the personalized attention they receive from coordinators and doctors. They note that the speed of diagnosis and the professionalism of the medical staff are particularly reassuring.

How long does the complete treatment program usually last?

Rhabdomyosarcoma treatment in Israel typically lasts between 6 and 12 months. This timeframe includes intensive chemotherapy, surgical tumor removal, and radiation therapy. High-volume JCI-accredited centers like Sourasky and Sheba manage these complex phases through multidisciplinary oncology protocols to ensure comprehensive care.

  • Diagnostic phase: Initial PET/CT, biopsy, and scintigraphy usually take 3 to 7 days.
  • Chemotherapy cycles: Primary treatment phases often span 6 to 9 months for stability.
  • Surgical intervention: Hospitalization for tumor removal typically lasts 5 to 10 days locally.
  • Radiation duration: If required, radiation therapy usually continues daily for 4 to 6 weeks.

Bookimed Expert Insight: Israeli oncology centers demonstrate high efficiency by integrating diagnostics and treatment starts within one week. While Sourasky Medical Center maintains a 90% success rate in oncology, patients should prepare for long-term stays. Most specialists at RAMBAM or Hadassah recommend remaining in Israel for at least the first three chemotherapy cycles to monitor the initial response.

Patient Consensus: Patients note that staying close to the hospital during intensive cycles is vital. They often emphasize that having a dedicated coordinator helps manage the long timeline between different therapy stages.

What late-effects surveillance is offered after therapy ends?

Late effects surveillance in Israel involves personalized long-term monitoring after rhabdomyosarcoma treatment ends. Specialists at centers like Sheba Medical Center coordinate cardiac tests, secondary cancer screenings, and endocrine evaluations. These protocols identify complications from chemotherapy or radiation years after initial therapy concludes.

  • Cardiac monitoring: Echocardiograms and ECGs check heart health after anthracycline chemotherapy.
  • Secondary screening: Annual imaging detects new malignancies, especially in previous radiation fields.
  • Endocrine checks: Blood tests monitor thyroid and hormone levels following head-neck radiation.
  • Organ function: Scintigraphy and PET/CT scans assess kidney and liver health.

Bookimed Expert Insight: Israeli oncology centers often follow international COG or SIOP guidelines. Dr. Iris Kventsel at Sheba Medical Center specifically specializes in genetic cancer predisposition. Patients at major centers frequently receive a detailed summary of lifetime cumulative doses. This data is vital for tailoring surveillance as the patient enters adulthood.

Patient Consensus: Patients emphasize the need to track specific drug doses and radiation fields. Many survivors note that hormone panels and hearing tests were essential follow-ups they had not initially anticipated.

Cała treść medyczna na tej stronie została przygotowana przez autorów z wykształceniem medycznym specjalistycznym i zweryfikowana przez certyfikowanych lekarzy w odpowiedniej dziedzinie. Recenzja medyczna: Fahad Mawlood, Redaktor medyczny, Data Scientist.

Ostatnia aktualizacja: May, 2026.

  • Statystyki: Dane opierają się na wewnętrznej bazie danych Bookimed z May 2026, która obejmuje analizę 12,450 zapytań pacjentów w 6 akredytowanych klinikach w Izrael.
  • Cennik: Informacje o kosztach są dostarczane bezpośrednio przez kliniki partnerskie Bookimed i regularnie aktualizowane, aby odzwierciedlać aktualne warunki rynkowe 2026. Rzeczywiste wydatki mogą się różnić w zależności od złożoności przypadku, doświadczenia chirurga i lokalizacji kliniki.
  • Dane Kliniczne: Wyniki leczenia i wskaźniki satysfakcji pacjentów są zbierane z zweryfikowanej bazy danych klinik Bookimed i poparte danymi ze źródeł medycznych poddanych recenzji naukowej, takich jak PubMed, The Lancet, JAMA i NEJM (2023–2026).

Wszystkie dane są dostarczane w celach ogólnie informacyjnych i mogą nie odzwierciedlać indywidualnych wyników lub doświadczeń.

Uzyskać bezpłatną konsultację

Proszę wybrać wygodny sposób komunikacji